Clover (CLV) Stock Price, News & Analysis

Company Overview

Clover Corporation Limited engages in the business of manufacturing, refining, and sale of tuna oil and encapsulated products in Australia, New Zealand, Asia, Europe, and the Americas. The company offers docosahexaenoic acid (DHA) tuna oils under the Nu-Mega HiDHA brand name for use in infant formula and pharmaceutical products; and cold pressed and refined tuna oils under the Ocean Gold brand name. It also provides DHA powders, including Nu-Mega Driphorm powders, used in a range of infant formula, follow-on formula, growing up milks, and food applications; Nu-Mega Driphorm HA for non-dairy applications; and microencapsulation. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 210,197 shs
• Average Volume: N/A
• Market Capitalization: A$70.14 million
• P/E Ratio: 45.69
• Dividend Yield: 1.79%
• Price Target: N/A
• Consensus Rating: N/A

CLV Stock Analysis - Frequently Asked Questions

How were Clover's earnings last quarter?

Clover Co. Limited (ASX:CLV) posted its earnings results on Wednesday, March, 21st. The company reported $0.02 earnings per share for the quarter. Clover had a trailing twelve-month return on equity of 2.29% and a net margin of 2.44%.

What other stocks do shareholders of Clover own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Clover investors own include FuelCell Energy (FCEL), Aurora Cannabis (ACB), Canoo (GOEV), Agenus (AGEN), Eos Energy Enterprises (EOSE), Femasys (FEMY) and Geron (GERN).

Company Calendar

• Last Earnings: 3/21/2018
• Today: 8/06/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: Business Services
• Current Symbol: ASX:CLV
• CIK: N/A
• Web: www.clovercorp.com.au
• Phone: +61-3-83475000
• Fax: N/A
• Employees: 33,700
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A$0.01
• Trailing P/E Ratio: 45.69
• Forward P/E Ratio: N/A
• P/E Growth: 0.73
• Net Income: A$1.51 million
• Net Margins: 2.44%
• Pretax Margin: N/A
• Return on Equity: 2.29%
• Return on Assets: 2.29%

Debt

• Debt-to-Equity Ratio: 15.49
• Current Ratio: 5.79
• Quick Ratio: 1.72

Sales & Book Value

• Annual Sales: A$62.21 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: -2,130.00
• Book Value: A$0.41 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 167,000,000
• Free Float: N/A
• Market Cap: A$70.14 million
• Optionable: Not Optionable
• Beta: 0.39